ANTARES PHARMA, INC. 4/A
4/A · ANTARES PHARMA, INC. · Filed Jun 29, 2015
Insider Transaction Report
Form 4/AAmended
HOBBS EAMONN P
Director
Transactions
- Award
Stock option (right to buy)
2015-05-28+293,670→ 293,670 totalExercise: $2.18Exp: 2025-05-27→ Common Stock (293,670 underlying) - Award
Common Stock
2018-05-28+245,532→ 445,254 total
Footnotes (5)
- [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. 2008 Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
- [F2]The shares reported here represent the total number of securities beneficially owned following the reported transaction, excluding awards of performance stock units previously reported as 182,724 shares of common stock that remain subject to the achievement of a performance goal pursuant to the terms of the award and thus were removed from the total amount of securities beneficially owned.
- [F3]Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
- [F4]The number of options granted has been reduced from 498,310 to 293,670 based on a determination by the Compensation Committee on June 25, 2015.
- [F5]The options vest in equal quarterly installments over three years from the date of grant.